Updated and contextualized version of an article originally published on March 5, 2020
The article retains its original focus by presenting it through a scholarly and accessible perspective, supported by verifiable references.
Authors
- Dr. M. Bitonti – Biologist
- Roberto Panzironi –Independent researcher
Note editoriali
- First publication: March 5, 2020
- Last update: April 20, 2026
- Version: 2026 narrative revision
Editorial Note
This article was previously published and has been updated according to scientific and divulgative criteria. The purpose is informative: it does not replace personalized medical advice. If you have persistent symptoms or questions about your health, consult a qualified healthcare professional.
IN BRIEF
- Short or irregular sleep is associated with an increased risk of cardiovascular events, stroke, hypertension, obesity, and type 2 diabetes.
- Plausible mechanisms involve systemic inflammation, neuroendocrine alterations, insulin resistance, and changes in eating behavior.
- Melatonin is a circadian regulator with antioxidant and immunomodulatory functions; its secretion tends to change with age.
- Evidence is largely observational; experimental studies also show biological responses to sleep deprivation.
- For practical choices, a cautious and personalized approach is recommended: improving sleep regularity and quality is consistent with reducing overall risk.
Abstract: what does science say?
The topic: the relationship between insufficient or irregular sleep and heart and brain health. The evidence: observational studies and meta-analyses show associations between short sleep (generally <6–7 hours) or irregular sleep and a higher risk of cardiovascular events, stroke, hypertension, type 2 diabetes, obesity, and cognitive decline. Plausible mechanisms: increased systemic inflammation, circadian misalignment, neuroendocrine and metabolic alterations. What depends on dose and context: the strength of the association varies with sleep duration, regularity, and the presence of sleep disorders such as apnea. Limitations: much evidence is observational and does not demonstrate direct causality; however, experimental studies of acute deprivation show biological changes consistent with prolonged damage. Practical implication: promoting regular and adequate sleep is a plausible public health strategy, to be interpreted with caution and in combination with other preventive measures.
Why sleep matters for heart and brain
Numerous observational studies and meta-analyses indicate that sleeping fewer hours than necessary or having irregular sleep is associated with an increased risk of cardiovascular and cerebrovascular diseases. A comprehensive systematic review and meta-analysis of hundreds of thousands of participants showed that sleep duration is linked to the risk of coronary heart disease and stroke: both too short sleep and, in some analyses, excessive sleep are associated with worse outcomes [1].
Specific analyses on stroke risk confirm a non-linear relationship between sleep hours and stroke incidence, with the lowest risk point around normal values (about 7 hours), while both marked deprivation and very prolonged sleep are associated with higher risks [2].
These associations also emerge in large international studies and in different populations, but the strength of the effect varies between investigations and depends on factors such as age, comorbidities, and the presence of clinical sleep disorders (e.g., obstructive apnea). For this reason, experts recommend evaluating sleep quality and regularity in addition to just quantity.
Biological mechanisms: inflammation, neuroendocrine, and metabolism
The biological explanations linking insufficient sleep and disease risk are multiple and interconnected. Controlled experimental studies and laboratory research show that sleep deprivation can activate inflammatory pathways (increasing the production of pro-inflammatory cytokines such as IL-6 and TNF-α), activate intracellular signals associated with inflammation, and modulate the immune response [6][7].
From a neuroendocrine perspective, sleep affects the sympathetic system (increasing adrenergic tone when sleep is deficient), the glucocorticoid profile, and hormones that regulate hunger and satiety; these alterations promote insulin resistance, increased appetite, and a tendency to gain weight. Population studies relate short sleep to a higher probability of hypertension [3] and metabolic syndrome, while longitudinal follow-ups associate insufficient sleep with a higher risk of obesity and type 2 diabetes [4][5].
Finally, circadian processes that regulate the sleep-wake rhythm and metabolic functions play a central role: disorganization of the biological rhythm (e.g., shift work or irregular rhythms) can amplify the adverse effects of insufficient sleep and increase exposure to cardiovascular and metabolic risk factors.
Melatonin: role, functions, and limitations of evidence
Melatonin is the main hormone of the pineal gland that signals darkness and contributes to the regulation of the circadian rhythm. In addition to its role in promoting sleep, experimental and review literature describes antioxidant, immunomodulatory, and possible vascular actions of melatonin; these mechanisms make a biological link between melatonin, sleep quality, and tissue protection plausible [8].
However, clinical evidence on the use of melatonin as a preventive therapy for cardiovascular diseases or for cancer prevention remains incomplete. Reviews show biological effects in cellular and animal models and some encouraging results in small clinical studies or in cancer patients, but the evidence is not sufficient to affirm a consolidated protective effect in healthy adults [9].
Decrease in melatonin with age (H3)
Melatonin secretion tends to change with advancing age: review papers have described an average reduction in nocturnal secretion in older people, although individual variability is high. This phenomenon has been documented in classic reviews and physiological studies and may contribute to the sleep changes typical of old age [10]. However, data vary by measurement methods and studied populations; therefore, it is prudent to avoid fixed numbers and recognize wide individual variability.
What the research says: main points of evidence
Summarizing the peer-reviewed evidence:
- Robust associations between short/irregular sleep and increased risk of coronary heart disease and stroke, emerged in meta-analyses of large-scale prospective studies [1][2].
- Consistent relationships between short sleep and hypertension in dose-response analyses [3].
- Longitudinal and meta-analytic evidence links short sleep to a higher risk of obesity and progression to type 2 diabetes; mechanisms include metabolic and behavioral alterations [4][5].
- Experimental studies on acute deprivation show increases in inflammatory markers and changes in immune function, supporting the biological plausibility of the observed association at the population level [6][7].
- Melatonin has antioxidant and immune system modulating properties in experimental models; however, clinical evidence remains limited and does not justify generalized recommendations for the prevention of chronic diseases [8][9][10].
What it means in practice
Interpreting this evidence in daily life requires caution. Research indicates that sleeping regularly and in adequate amounts is part of a lifestyle favorable to cardiometabolic and cognitive health: it promotes metabolic balance, reduces chronic inflammatory states, and supports cognitive functions. However, most evidence comes from observational studies: this means that sleep can be both a cause and a marker (signal) of health or disease.
In daily practice, the operational ideas derived from the evidence are moderate: promote regular sleep-wake times, limit evening exposure to intense light and screens, curb caffeine and alcohol consumption in the hours before rest, and consult a professional if sleep disorders are suspected (e.g., apnea, chronic insomnia). Expert organization recommendations suggest that most adults should aim for at least 7 hours of sleep per night regularly, with individual adaptations [11].
Limitations of the evidence
It is important to distinguish between observational associations and evidence of causality. Many studies are based on self-reported sleep, which is subject to bias, and may not account for all confounding variables (e.g., undiagnosed sleep apnea, pre-existing health status, shift work). Meta-analyses offer robust syntheses but reflect the limitations of the original studies.
Experimental deprivation studies show biological changes consistent with risk mechanisms (increased cytokines, metabolic alterations), but experimental exposure is usually acute and not equivalent to insidious chronic patterns observed in real life. Therefore, direct translation from laboratory to public health requires caution.
Finally, individual variability (age, genetics, chronotype, co-morbidities) affects both the amount of sleep needed and the biological response to its lack; therefore, general recommendations must be personalized.
Key takeaways
- Short and irregular sleep are associated with an increased cardiovascular and metabolic risk in observational studies [1][2][4][5].
- Plausible mechanisms include increased inflammation, neuroendocrine alterations, and circadian misalignment [6][7].
- Melatonin supports the sleep-wake rhythm and has antioxidant actions; clinical evidence for systemic preventive uses is still limited [8][9][10].
- Much evidence is observational: be careful not to automatically interpret association as direct causation.
- Improving sleep regularity and quality (in addition to quantity) is a plausible and low-risk intervention to consider in health promotion.
Editorial conclusion
Accumulated evidence indicates that sleep is a relevant factor for heart and brain health. The association between insufficient or irregular sleep and many adverse outcomes is supported by population studies and experimental results that explain its biological plausibility. It remains essential to interpret these data rigorously: many studies are observational, and direct causality is not always demonstrated. Overall, promoting habits that improve sleep regularity and quality is consistent with general preventive recommendations and can be part of a broader strategy to reduce the risk of chronic diseases.
Editorial note (closing)
The article has been updated by integrating a review of peer-reviewed literature and consensus evidence. Informative purpose: it does not constitute clinical recommendation. For specific problems, consult your doctor or a sleep specialist.
SCIENTIFIC RESEARCH
- Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011. https://doi.org/10.1093/eurheartj/ehr007
- Wang X, et al. Sleep duration and risk of stroke: a dose–response meta-analysis of prospective cohort studies. Sleep. 2016. https://doi.org/10.1016/j.sleep.2016.12.012
- Wang M, et al. Correlation between sleep duration and hypertension: a dose-response meta-analysis. J Hum Hypertens. 2018. https://doi.org/10.1038/s41371-018-0135-1
- Wu Y, Zhai L, Zhang D. Sleep duration and obesity among adults: a meta-analysis of prospective studies. Sleep. 2014. https://doi.org/10.1016/j.sleep.2014.07.018
- Shan Z, Ma H, Xie M, et al. Sleep duration and risk of type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2015;38(3):529-537. https://doi.org/10.2337/dc14-2073
- Irwin MR, Witarama T, Caudill M, Olmstead R, Breen EC. Sleep loss activates cellular inflammation and signal transducer and activator of transcription (STAT) family proteins in humans. Brain Behav Immun. 2015. https://doi.org/10.1016/j.bbi.2014.09.017
- Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med. 2006. https://doi.org/10.1001/archinte.166.16.1756
- Reiter RJ, Tan DX, et al. Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res. 2014. https://doi.org/10.1111/jpi.12162
- Bondy SC, Campbell A. Mechanisms underlying tumor suppressive properties of melatonin. Int J Mol Sci. 2018. https://doi.org/10.3390/ijms19082205
- Brzezinski A. Melatonin in humans. N Engl J Med. 1997. https://doi.org/10.1056/NEJM199701163360306
- American Academy of Sleep Medicine; Sleep Research Society. Recommended Amount of Sleep for a Healthy Adult: a joint consensus statement. Sleep. 2015. https://doi.5665/sleep.4716